Combidex aids in early lymph node metastasis detection

Advanced Magnetics' Combidex MRI contrast agent aids in the non-invasive evaluation of lymph nodes in prostate cancer patients, according to clinical data published in this week's New England Journal of Medicine. Researchers from the Massachusetts General Hospital and University Medical Center Nijmegen in the Netherlands concluded that Combidex-enhanced MRI allows for the detection of small and otherwise undetectable lymph node metastases in prostate cancer patients, according to Advanced Magnetics of Cambridge, MA, and marketing partner Cytogen of Princeton, NJ.

By AuntMinnie.com staff writers
June 19, 2003

Related Reading

ASNR papers highlight Combidex for tumor imaging, April 30, 2003

Advanced Magnetics falls into red in Q1, January 16, 2003

Advanced Magnetics revenues decline, November 25, 2002

NCI to study Advanced Magnetics agents, October 1, 2002

Copyright © 2003 AuntMinnie.com

Page 1 of 611
Next Page